Introduction. In this population-based register study our objective was to explore the association of cervical intraepithelial neoplasia, grade 1 and loop electrosurcigal excision procedure with preterm birth. Material and methods. Our population consisted of 4759 women diagnosed with cervical intraepithelial neoplasia, grade 1 during 1997-2009 and their 3021 subsequent deliveries analyzed by loop electrosurcigal excision procedure and parity. Hospital Discharge Register was used to identify women diagnosed for cervical intraepithelial neoplasia, grade 1 and these data were linked with the Medical Birth Register data. We calculated odds ratios with 95% confidence intervals. Results. Cervical intraepithelial neoplasia, grade 1 patients with loop electrosurcigal excision procedure had 54 (6.7%) subsequent preterm births and the corresponding figure among cervical intraepithelial neoplasia, grade 1 patients without loop electrosurcigal excision procedure was 116 (5.2%). This results in odds ratios 1.31 (95% confidence interval 0.94-1.83). We assessed the risk before and after diagnosis of cervical intraepithelial neoplasia, grade 1 both for patients with loop electrosurcigal excision procedure (odds ratios 1.47, 95% confidence interval 1.05-2.06) and without loop electrosurcigal excision procedure (odds ratios 0.90, 95% confidence interval 0.71-1.13). An increased risk for preterm birth after diagnosis of cervical intraepithelial neoplasia, grade 1 and loop electrosurcigal excision procedure was observed. We also compared both groups to the background population in the Medical Birth Register. For cervical intraepithelial neoplasia, grade 1 patients without loop electrosurcigal excision procedure the risk for preterm birth was not increased (odds ratios 0.95, 95% confidence interval 0.76-1.21) whereas for cervical intraepithelial neoplasia, grade 1 patients treated with loop electrosurcigal excision procedure the risk for preterm birth was increased (odds ratios 1.45, 95% confidence interval 1.02-1.92). Conclusions. Loop electrosurcigal excision procedure itself increases the risk for preterm birth. Cervical intraepithelial neoplasia, grade 1 as such does not increase the risk for preterm birth.
Introduction
Cervical intraepithelial neoplasia (CIN) is a precancerous lesion common in reproductive aged women (1) . According to the latest World Health Organization classification, lesions can be classified as low-grade squamous intraepithelial lesions including CIN1 (or dysplasia levis) lesions and high-grade squamous intraepithelial lesions including CIN2 and CIN3 (dysplasia moderata and gravis) lesions. The most common treatment for CIN is loop electrosurgical excision procedure (LEEP). LEEP has been associated with an increased risk for preterm birth (PTB), adverse pregnancy outcomes and low birthweight in several studies (2) (3) (4) and the risk has been shown to further increase with the length of the excised LEEP cone (5) .
Most studies exploring the risk of PTB associated with LEEP have used external reference groups generated from the general population (2, 3) and this has raised questions about whether the risk of PTB is actually increased by the LEEP procedure, or by CIN itself, or human papillomavirus (HPV) infection. Some studies have used internal reference groups comparing deliveries before and after the LEEP (4, 6) . Only a few studies have used CIN patients without surgical treatment as a comparison group (7) . Such a comparison group would be an advantage to study the association between LEEP and PTB. Some risk factors may be more prevalent among patients with HPV than in the general population, i.e. smoking.
In 2007 an update of the Current Care Guideline was published in Finland. It recommended that patients with a CIN1 lesion should be followed for 24 months to identify persistent lesions instead of immediate treatment (www.kaypahoito.fi). This allowed us to compare CIN1-diagnosed women with or without LEEP treatment. Our goal in this population-based cohort study was to find out whether the risk of PTB is associated with LEEP or with CIN diagnosis itself.
Material and methods
We used the Hospital Discharge Register to identify women diagnosed with CIN1 between 1997 and 2011. We divided these women into two groups according to whether or not they had LEEP treatment. Then we linked this information with the Medical Birth Register (MBR) data to identify all their deliveries since 1987. The data linkage was performed by using the unique encrypted personal identification numbers.
Both registries are run by the National Institute of Health and Welfare (THL). The Hospital Discharge Register collects information on all hospitalizations since 1967. It includes day surgical procedures since 1994 and outpatient visits since 1998 (8) . The medical procedures performed at hospitals are identified by surgical procedure codes [since 1997 based on the Finnish version of Nordic Medico-Statistical Committee (NOMESCO) Classification on Surgical Procedures]. The MBR is a nationwide population-based register and it comprises baseline data of pregnant women and their health and all interventions during pregnancy and delivery as well as information on the newborn outcome during the first 7 days. Less than 0.1% of all newborns are missing from the register and information of such cases is routinely obtained from the Central Population Register and Cause-of-Death Register. The information in the MBR is controlled by the National Institute of Health and Welfare (THL) and incorrect information is sent back for revision (9) .
Preterm birth was defined as delivery before 37 weeks of gestation. The CIN1 patients aged less than 45 years were identified using the disease code N87.0 for CIN1 according to the 10th revision of the International Classification of Diseases (ICD-10), n = 6837 (3502 before the 2007 Current Care Guideline update and 3335 after it). The Finnish version of the NOMESCO Classification of Surgical Procedures has used the LCD03 code for LEEP exclusively (excluding cold knife conization and laser treatments) since 1997 and it was used to identify CIN1 patients treated with LEEP. We excluded patients with previous LEEP (n = 1612) diagnosed subsequently with more severe dysplasia (N87.1, CIN2 n = 385 and N87.2, CIN3 n = 182), and carcinoma in situ of cervix (D06.0, D06.1, D06.7 and D06.9, n = 15). There were no cases of cervical carcinoma (C53). The total number of women with CIN1 diagnosis was 4759. Of these women, 2006 had LEEP (51% of women in the first period and 32% in the second period). These women had 4496 deliveries before the diagnosis and 3017 after the diagnosis.
Our cases consisted of 2006 women with CIN1 diagnosis and LEEP treatment and their 797 subsequent deliveries of which 334 were primiparous and 463 were multiparous. Our controls consisted of 2753 women with CIN1 diagnosis but without LEEP and their 2220 subsequent deliveries of which 977 were primiparous and 1243 multiparous ( Table 1) .
We calculated odd ratios (OR) and 95% CI for PTB by using logistic regressions. We adjusted the results for maternal age, socio-economic status based on mother's
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Results
The characteristics of the study population are shown in Table 1 . The mean age of women diagnosed with CIN1 and LEEP was 31.4 years. For women with CIN1 and no LEEP the mean age was 30.1 years (p < 0.001). All women diagnosed for CIN1 with or without LEEP smoked more often (28.0% and 21.9%, respectively) than women in MBR (15.9%, p < 0.001). Nearly 90% of the PTBs were late PTBs between 32 and 36 +6 weeks of gestation. Women with CIN1 diagnoses and LEEP did not differ from women with CIN1 and no LEEP with regards to socio-economic status, marital status, urbanism, gestational age, or parity.
The CIN1 patients treated with LEEP had 54 (6.7%) subsequent preterm deliveries whereas the corresponding figure among CIN1 patients without LEEP was 116 (5.2%) (OR 1.31, 95% CI 0.94-1.83) ( Table 2 ). Adjustments for background variables did not change the result. The same analysis was performed for multiparous deliveries (OR 1.49, 95% CI 0.93-2.37), and for primiparous deliveries (OR 1.12, 95% CI 0.69-1.83).
We analyzed separately the risk for PTB (Table 3 ) before and after the diagnosis of CIN1. The risk for PTB was significantly increased after LEEP (OR 1.47, 95% CI 1.05-2.06), whereas for CIN1 patients without LEEP the risk was not increased (OR 0.90, 95% CI 0.71-1.13). We analyzed multiparous deliveries separately and detected the same increased risk among CIN1 patients treated with LEEP (OR 1.89, 95% CI 1.15-3.12), but the risk was not increased in patients without LEEP (OR 0.75, 95% CI 0.53-1.05). When only primiparous deliveries were analyzed no increase in risk for PTB was detected in either group.
Women with CIN1 were then compared with the background population in the MBR. The risk for PTB was increased for CIN1 patients with LEEP when compared with all singleton deliveries in the MBR (OR 1.45, 95% CI 1.02-1.92) ( Table 4) whereas for CIN1 patients without LEEP the risk was not increased. For multiparous deliveries the risk for PTB was increased for patients treated with LEEP (OR 1.59, 95% CI 1.09-2.32) but not for untreated patients. Again, when analyzing primiparous deliveries only, no increased risk for PTB was found in either group.
The risk for small for gestational age was increased in neither group when compared with the MBR data (Table 4 ). However, for CIN1 patients with LEEP the risk for low birthweight was increased when analysing multiparous deliveries only (OR 1.91, 95% CI 1.26-2.90). This risk was not increased among CIN1 patients without LEEP.
After the update of Current Care Guidelines in 2007 the number of LEEPs has declined. Indeed, 51% of CIN1 patients were treated with LEEP before the update and only 32% after the update.
Discussion
We found that the increased risk for PTB was associated with LEEP rather than with CIN diagnosis itself. Untreated patients with CIN1 had no increased risk for PTB compared with the background population in the MBR. The risk for PTB did not change for untreated CIN1 patients when analyzing before and after the diagnoses. For CIN1 patients with LEEP we found the risk for PTB to be increased compared with the background population. The risk for PTB increased after the procedure when compared with that before the procedure. When comparing CIN1 patients with LEEP to untreated CIN1 patients we observed only a statistically insignificant increase in preterm deliveries in the LEEP group.
CIN1 is an HPV-related often regressing cervical lesion and only 10% of cases progress into more severe lesions (12, 13) . In younger patients, almost 60% of CIN1 regress spontaneously in 12 months (14) . Hence, CIN1 lesions (i.e. low-grade squamous intraepithelial lesions) are currently seldom managed with LEEP, only if the lesion persists for 24 months, or the transformation zone cannot be visualized. This highlights the importance of our study because such a large cohort of women with CIN1 diagnosis and LEEP will not be available in the future. During our study period we already observed a decline in the number of LEEPs performed in this population. It has been shown in multiple studies (5, 15) and in a recent meta-analysis that the risk for PTB increases with the length of the excised cone (16) . Unfortunately, we did not have information concerning the length of the excised cones because this information is not collected in the register. Because our patients had minor CIN1 lesions it can be assumed that the LEEP cones were not very large and therefore the risk for PTB was not increased.
A strength of our study is the use of the high-quality Finnish MBR and Hospital Discharge Register data, giving us a large study population with the absence of reporting, recall and participation bias improving the quality and credibility of our results. We were able to adjust for the most important known risk factor for PTB, i.e. history of previous PTB. We were also able to exclude all more severe lesions and cancers. We also adjusted for maternal smoking, which is a known risk factor for PTB and strongly correlated to socio-economic status in Finland (17) .
The ultimate strength of our study is the use of multiple different comparison groups, especially the use of untreated CIN1 patients as a comparison group. It gave us further insight into whether the risk associated with PTB is actually associated with LEEP or CIN itself. It has been debated that the use of MBR controls overinflates the risk for PTB, but in our study the results for treated women compared with MBR were in line with results comparing the risk before and after diagnoses.
Our study has some limitations. We divided CIN1 patients into two groups according to whether they had been treated or not. It is possible that the patients who were treated immediately were older and that lesions were interpreted to be more severe by colposcopy. Not all the potential confounding factors for PTB could be accounted for. Hence, the possibility of a type II error in the primiparous population exists. When analysing primiparous deliveries only, the risk for PTB was not increased after LEEP. A short interval between pregnancies increases the risk of subsequent PTB (18) and this could partly explain the difference between primiparous and multiparous populations.
The risk for PTB associated with LEEP has been demonstrated in many meta-analyses (16, 19, 20) and single studies (2) (3) (4) . A very recent population-based cohort study from Norway demonstrated an increased risk associated with all excisional types of treatment of CIN (21) . They also found an association between surgical treatment and spontaneous abortion and stillbirth. A recent meta-analysis found an association between second-trimester miscarriages and LEEP but this association needs to be further investigated (22) . There have only been a few reports of the risk of PTB associated with LEEP that used internal comparison groups. One of these (7) investigated the risk for PTB for untreated CIN3 patients. They observed an increased risk when comparing with an unexposed population in the national data but no difference when comparing them with LEEP-treated CIN3 patients. This suggests that CIN itself could increase the risk. However, patients with poor compliance to CIN3 treatment could be presumed to possess other predisposing factors to PTB such as lower socio-economic status, sexually transmitted infections, short education, or smoking. In another study (23) the comparison group was colposcopy clinic patients without surgical treatment and they still found that LEEP was a risk factor for PTB, which is in line with our results.
A recent American study found that a previous excisional procedure in the absence of dysplasia was associated with PTB. They assessed women who underwent cervical length screening during 18-23 weeks of gestation stratified by no previous dysplasia, dysplasia with excisional procedure, and dysplasia with no procedure. The risk associated with excisional procedure was independent of cervical length shortening (24) . Their result is in line with our findings and supports our finding that the increased risk of PTB is associated with LEEP itself.
Conclusions
Increased risk for PTB seems to be associated with LEEP itself. Because of the high spontaneous regression rate and the knowledge of the increased risk for PTB the treatment of CIN1 with LEEP should be avoided, especially in young women.
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